Scientific Award / Research Funding

Yahia Lodi MD, Co-investigator: Scientist Development Award.

American Heart Association-New York State Affiliate. Buffalo Metropolitan

Area and Erie County Stroke Study. 7-1-2002 – 6-30-2005,  

(10% effort each). $ 48,986/year

 

Yahia Lodi MD, Co-investigator: Validation of an In-Vivo (Porcine)

Model of Arterial Blockage Derived Using Homologous /Autologous Clots/

Thrombi created in-Vitro. Boston Scientific, Fremont, CA. December 2001                

$17,780

 

Yahia Lodi MD, Co-investigator: A Prospective Registry to Assess the

Safety and Efficacy of Intravenous Eptifibatide in Patients Undergoing Carotid

Angioplasty and Stent Placement. Funded by Centacore Therapeutics. 2001 – 2002.     $40,000

 

Yahia Lodi MD, Investigator: A randomized comparison of intravenous alteplase and intra-arterial reteplase in a canine model of basilar thrombolysis. Funded by Dent Neurological Institute. Educational Grant. 2001 – 2002.       $20,000                                                                                          

 

Yahia Lodi MD, Co-investigator: A prospective study of intra-arterial

Reteplase and intravenous abciximab for patients with acute ischemic stroke.

Funded by Centacore therapeutics. 2001-2002.   $200,000

 

Yahia Lodi MD, Co-investigator: In-Vivo (Porcine) Model of

Arterial Blockage Derived Using Homologous /Autologous Clots/Thrombi

Created in-Vitro. Funded by Boston Scientific, Fremont, CA. March 2002.  $18,478

 

Yahia Lodi MD, Investigator: A prospective study in evaluating the role of Cardiac magnetic resonance imaging in the detection of source of emboli in patients with acute cerebral ischemic event and its comparison with Trans-esophageal echocardiography,  funded by Dent Foundation and Dent Neurological Institution. Educational grant.  January 2001 – September 2002.   $120,000 

 

Yahia Lodi MD, Co-investigator: Role of hypothermia in outcome of 

Patients with massive non-traumatic intracerebral hemorrhage. Funded by Dent Foundation educational grant. 2002 – 2003.     $167,000

 

Yahia Lodi MD, Co-investigator: Funded by Kirby Foundation – center grant on cerebral ischemia. 2002 – 2003. $ 50, 000  

 

Yahia Lodi MD, Investigator: Michigan State University, Startup fund on “Dose-escalation of intra-arterial glycoprotein IIb/IIIa  (abciximab/Integrilin) antagonists with or without primary mechanical thrombolysis versus dose- escalation of intra-arterial reteplase with or without mechanical thrombolysis in the rate of earliest recanalization of thrombus occluded blood vessel of canine ischemic stroke model”. 2004 –2005. $ 400,000

 

Yahia M Lodi MD, Investigator: Department of Neurology, Upstate Medical University, Startup fund on “Dose-escalation of intra-arterial glycoprotein IIb/IIIa  (abciximab/Integrilin) antagonists with or without primary mechanical thrombolysis versus dose- escalation of intra-arterial reteplase with or without mechanical thrombolysis in the rate of earliest recanalization of thrombus occluded blood vessel of canine ischemic stroke model”. 2007 -2008. $ 60,000

 

Yahia M Lodi., FAHA. C0-PI: Developing Novel Optimization Based Learning Systems for Detection and Interpretation of Brain Aneurysm. Funded by SUNY Research Foundation. 50,000/Year for 2 years. (2013 to 2015).

 

Yahia M Lodi, MD, FAHA, FAAN. PI: Gaze weakness Neglect and Speech (GWNS); an acute ischemic stroke scale for rapid identification of large vessel occlusion (LVO). 2020 to 2021. This prospective study is ongoing and enrolling patients. This scale will be able to identify stroke patients with LVO in less than 60 second and potentially prevent delay and avoid radiation related to CT angiogram.

 

Yahia M Lodi, MD, FAHA, FAAN. PI: Dizziness, Diplopia, Imbalances, Ophthalmoplegia and Weakness (D2IOW); a unique posterior circulation stroke scale, which will specifically evaluate the patient with acute ischemic stroke in the posterior circulation that are not addressed by current NIHSS.  2020 to 2022.

Participation in Funded Clinical Trials

  1. AngioJet In Middle Cerebral Artery Embolism (TIME!) – Site PI (Neurologist), SUNY, Buffalo, NY, 2001 –2002

 

  1. NEUROLINK feasibility study – an evaluation of the NEUROLINK stent for the treatment of subject with symptomatic atherosclerotic lesions in extracranial vertebral or intracranial arteries – Site PI (Neurologist), SUNY, Buffalo, NY, 2001 –2002

 

  1. US Onyx Cerebral Aneurysm Feasibility Trial – Site PI (Neurologist), SUNY, Buffalo, NY, 2001 –2002

 

  1. Stenting and angioplasty with protection in patients at high-risk for endarterectomy – Site PI (Neurologist), SUNY, Buffalo, NY, 2001 –2002

 

  1. Feasibility study of the Endo Tex Coiled Sheet Stent in the treatment of carotid arterial stenosis – Site PI (Neurologist), SUNY, Buffalo, NY, 2001 –2002

 

  1. Ultrasound Facilitated Thrombolytic Treatment of Acute Thrombotic or Thromboembolic Stroke, a Feasibility Study – Site PI (Neurologist), SUNY, Buffalo, NY, 2001 –2002

 

  1. Randomized Clinical Trial Carotid Revisualization Endarterectomy – Stenting Trial (CREST) – Site PI (Neurologist), SUNY, Buffalo, NY, 2001 –2002

 

  1. Carotid Angioplasty – stenting Free of Emboli “CAFÉ” study – Site PI (Neurologist), SUNY, Buffalo, NY, 2001 –2002

 

  1. “Study of High Surgical Risk Patients with Extracranial Carotid Artery Stenosis using the Bard Memotherm Carotid Stent” – Site PI (Neurologist), SUNY, Buffalo, NY, 2001 –2002

 

  1. Medtronic AVE Aneurysm Feasibility Study Phase 11 – Site PI (Neurologist), SUNY, Buffalo, NY, 2001 –2002

 

  1. ACCULINK for Revisualization of Carotid in High Risk Patients “The ARCHeR Trial” – Site PI (Neurologist), SUNY, Buffalo, NY, 2001 –2002

 

  1. A prospective, non-randomized, multi-center feasibility study to assess the safety of the ACCUNET embolic protection system with the ACCULINK carotid stent system in the treatment of patients with lesions in the internal carotid artery (ICA) – Site PI (Neurologist), SUNY, Buffalo, NY, 2001 –2002

 

  1. Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke (SENTIS), Site PI, Michigan State University, East Lancing, MI. 2005.

 

  1. Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke (SENTIS), Site Co-PI, St. Joseph Oakland Mercy Hospital, MI. 2006.

 

  1. Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke (SENTIS), Site Co-PI, Providence Hospital, Southfield, MI. 2006.

 

  1. Carotid Occlusion Surgery Study (COSS), NIH funded study, Site PI, Michigan State University, East Lancing, MI. 2005.

 

  1. Matrix and Platinum Sciences (MAPS), Funded by Boston Scientific Corporation Site Co-PI, Providence Hospital, ST. John Health, Southfield, MI. 2006.

 

  1. Albumin in Acute Ischemic Stroke (ALIAS), NIH funded study, Site Co-PI, Providence Hospital, ST. John Health, Southfield, MI. 2006.

 

  1. A Randomized Trial of Unruptured Brain AVMs (ARUBA), NIH funded Study, Site Co-PI, Providence Hospital, ST. John Health, Southfield, MI. 2006.
  2. Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke (SENTIS), funded by COXIA corporation, Site PI, Upstate Medical University/University Hospital, Syracuse, NY 2007.

 

  1. Albumin in Acute Ischemic Stroke (ALIAS), NIH funded study, Site-PI, Upstate Medical University/University Hospital, Syracuse, NY 2007.

 

  1. CLEAR IVH (Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage) Trial, a NIH funded Trial: Site PI, Upstate Medical University/University Hospital, Syracuse, NY 2007.

 

  1. IMS – III (Interventional Management of Stroke III) is a NIH funded study. Site PI, Upstate Medical University/University Hospital, Syracuse, NY 2007. $ 12000/enrollment.

 

  1. Treatment of Wide-Necked Aneurysms with Neuroform Microdelivery Stent. Funded by Boston Scientific Corporation, Site Co-PI, Upstate Medical University/University Hospital, Syracuse, NY 2007.

 

  1. Treatment of Wide-Necked Aneurysms with Neuroform Microdelivery Stent. Funded by Boston Scientific Corporation, Site PI, Wilson Memorial Hospital/SUNY, Johnson City, NY 2008.

 

  1. Wingspan Stent System with Gateway PTA Balloon Catheter for the treatment of symptomatic intracranial atherosclerotic stenosis. Funded by Boston Scientific Corporation. Site Co-PI, Upstate Medical University/University Hospital, Syracuse, NY 2007.

 

  1. Wingspan Stent System with Gateway PTA Balloon Catheter for the treatment of symptomatic intracranial atherosclerotic stenosis. Funded by Boston Scientific Corporation. Site PI, Site PI, Wilson Memorial Hospital/SUNY, Johnson City, NY 2008.

 

  1. Cerecyte Registry: Evaluation of Outcomes after Embolization of Intracranial Aneurysms with the Micrus Cerecyte MicroCoil System. Site Co-PI, Upstate Medical University/University Hospital, Syracuse, NY 2007. $ 1500/enrollment.

 

  1. CORDIS ENTERPRISE™ Vascular Reconstruction Device and Delivery System – A Humanitarian Use Device (HUD). Site Co-PI, Upstate Medical University/University Hospital, Syracuse, NY 2007.

 

  1. CORDIS ENTERPRISE™ Vascular Reconstruction Device and Delivery System – A Humanitarian Use Device (HUD). Site PI, Wilson Memorial Hospital/SUNY, Johnson City, NY 2008.